{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:16:19Z","timestamp":1793423779130,"version":"4.5.0"},"reference-count":136,"publisher":"Centers for Disease Control MMWR Office","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Recomm. Rep."],"DOI":"10.15585\/mmwr.rr7003a1","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T07:43:26Z","timestamp":1626335006000},"page":"1-27","source":"Crossref","is-referenced-by-count":76,"title":["Antimicrobial Treatment and Prophylaxis of Plague: Recommendations for Naturally Acquired Infections and Bioterrorism Response"],"prefix":"10.15585","volume":"70","author":[{"given":"Christina A.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Meaney-Delman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Fleck-Derderian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine M.","family":"Cooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Mead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R1","unstructured":"Mead PS. Plague (\n                      Yersinia pestis\n                      ) In: Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases. 9th ed. Philadelphia, PA: Elsevier Saunders; 2019."},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R2","unstructured":"Dennis DT, Gage KL, Gratz N, Poland JD, Tikhomirov E. Diagnosis and clinical manifestations. In: Plague manual: epidemiology, distribution, and surveillance and control. Geneva: World Health Organization;1999:43\u201354."},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3201\/eid2101.140564","article-title":"Epidemiology of human plague in the United States, 1900\u20132012.","volume":"21","author":"Kugeler","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R4","doi-asserted-by":"crossref","unstructured":"Yang R, Cui Y, Bi Y. Perspectives on\n                      Yersinia pestis\n                      : A model for studying zoonotic pathogens. In: Yang R., Anisimov A, eds.\n                      Yersinia pestis\n                      : retrospective and perspective. Advances in experimental medicine and biology. Springer, Dordecht; 2016:918;377\u201391.","DOI":"10.1007\/978-94-024-0890-4_14"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R5","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/S0140-6736(07)60566-2","article-title":"Plague.","volume":"369","author":"Prentice","year":"2007","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.idc.2006.02.004","article-title":"Plague: disease, management, and recognition of act of terrorism.","volume":"20","author":"Koirala","year":"2006","journal-title":"Infect Dis Clin North Am"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2010.00119","article-title":"Model systems to study plague pathogenesis and develop new therapeutics.","volume":"1","author":"Lawrenz","year":"2010","journal-title":"Front Microbiol"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R8","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a biological weapon: medical and public health management.","volume":"283","author":"Inglesby","year":"2000","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R9","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1086\/428617","article-title":"Risk of person-to-person transmission of pneumonic plague.","volume":"40","author":"Kool","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3201\/eid2101.131828","article-title":"Pneumonic plague outbreak, Northern Madagascar, 2011.","volume":"21","author":"Richard","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R11","doi-asserted-by":"publisher","first-page":"910","DOI":"10.2353\/ajpath.2009.071168","article-title":"Pneumonic plague pathogenesis and immunity in Brown Norway rats.","volume":"174","author":"Anderson","year":"2009","journal-title":"Am J Pathol"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R12","first-page":"554","article-title":"Plague meningitis\u2014a retrospective analysis of cases reported in the United States, 1970\u20131979.","volume":"147","author":"Becker","year":"1987","journal-title":"West J Med"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R13","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1099\/jmm.0.46697-0","article-title":"Treatment of plague: promising alternatives to antibiotics.","volume":"55","author":"Anisimov","year":"2006","journal-title":"J Med Microbiol"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R14","first-page":"173","article-title":"Five cases of primary pneumonic plague with three cured.","volume":"39","author":"Roux","year":"1946","journal-title":"Bull Soc Pathol Exot"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1001\/jama.1945.92860210002009b","article-title":"Pneumonic plague: Report of a case with recovery.","volume":"128","author":"Munter","year":"1945","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R16","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1093\/cid\/ciz1227","article-title":"Antimicrobial treatment patterns and illness outcome among United States patients with plague, 1942\u20132018.","volume":"70","author":"Kugeler","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R17","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1086\/500137","article-title":"Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania.","volume":"42","author":"Mwengee","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R18","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3201\/eid2303.161212","article-title":"Successful treatment of human plague with oral ciprofloxacin.","volume":"23","author":"Apangu","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R19","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1093\/cid\/ciz1226","article-title":"Antibiotic treatment of human plague: a systematic review of the literature on individual cases, 1937\u20132019.","volume":"70","author":"Nelson","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R20","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1542\/peds.40.4.610","article-title":"Plague meningitis. A report of three cases in children and review of the problem.","volume":"40","author":"Martin","year":"1967","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R21","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1093\/cid\/ciz1228","article-title":"Plague during pregnancy: A systematic review.","volume":"70","author":"Fleck-Derderian","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R22","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3201\/eid1203.051051","article-title":"Pneumonic plague cluster, Uganda, 2004.","volume":"12","author":"Begier","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R23","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1017\/S0950268811001245","article-title":"Transmission dynamics of primary pneumonic plague in the USA.","volume":"140","author":"Hinckley","year":"2012","journal-title":"Epidemiol Infect"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R24","unstructured":"Butler T. Plague and other\n                      Yersinia\n                      infections. In: William Greenough III & Thomas Merigan, ed. Current Topics In Infectious Disease. 1st edition. New York: Plenum Medical Book Company; 1983."},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R25","first-page":"429","article-title":"Outbreak of human pneumonic plague with dog-to-human and possible human-to-human transmission\u2014Colorado, June\u2013July 2014.","volume":"64","author":"Runfola","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R26","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1473-3099(18)30730-8","article-title":"Epidemiological characteristics of an urban plague epidemic in Madagascar, August-November, 2017: an outbreak report.","volume":"19","author":"Randremanana","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R27","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1590\/S1726-46342010000300004","article-title":"Primary pneumonic plague with nosocomial transmission in La Libertad, Peru 2010","volume":"27","author":"Donaires","year":"2010","journal-title":"Rev Peru Med Exp Salud Publica"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R28","doi-asserted-by":"publisher","first-page":"923","DOI":"10.4269\/ajtmh.12-0163","article-title":"A cluster of primary pneumonic plague transmitted in a truck cab in a new enzootic focus in China.","volume":"88","author":"Luo","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/cid\/ciq107","article-title":"A dog-associated primary pneumonic plague in Qinghai Province, China.","volume":"52","author":"Wang","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R30","unstructured":"Federal Select Agent Program. Biosafety\/biocontainment plan guidance. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2020. https:\/\/www.selectagents.gov\/compliance\/guidance\/biosafety\/definitions.htm#:~:text=Tier%201%20Select%20agents%20and,economy%2C%20critical%20infrastructure%2C%20or%20public"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1128\/CMR.00033-15","article-title":"Bioterrorism and the role of the clinical microbiology laboratory.","volume":"29","author":"Wagar","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R32","unstructured":"Federal Select Agent Program. Select agents and toxins list. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2020. https:\/\/www.selectagents.gov\/sat\/list.htm"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R33","unstructured":"World Health Organization. Health aspects of chemical and biological weapons; Report of a WHO group of consultants. 1st ed. Geneva: World Health Organization; 1970."},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jobb.2020.02.001","article-title":"Deliberate release: Plague - A review.","volume":"2","author":"Ansari","year":"2020","journal-title":"J Biosaf Biosecur"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R35","unstructured":"Eitzen EM, Takafuji ET. Historical overview of biological warfare. In: Sidell FR, Takafuji ET, Franz DR. Military medicine: Medical aspects of chemical and biological warfare. Office of the Surgeon General, Department of the Army, Walter Reed Army Medical Center, 1997:415\u201323."},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.idc.2006.03.001","article-title":"Impact of plague on human history.","volume":"20","author":"Cunha","year":"2006","journal-title":"Infect Dis Clin North Am"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R37","unstructured":"Alibek K, Handelman S. Biohazard: the chilling true story of the largest covert biological weapons program in the world, told from the inside by the man who ran it. New York, NY: Random House; 1999."},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R38","unstructured":"Low P-M. Paul. The role of Veterans Affairs in support of DOD in biodefense. https:\/\/apps.dtic.mil\/docs\/citations\/AD1001643"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R39","unstructured":"Griffin A. Isis laptop reveals terror group \u2018wants to turn bubonic plague into a weapon of war\u2019. Independent. August 31, 2014. https:\/\/www.independent.co.uk\/news\/world\/middle-east\/seized-isis-laptop-reveals-wmd-plans-9702030.html"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R40","doi-asserted-by":"publisher","first-page":"S183","DOI":"10.2105\/AJPH.2018.304472","article-title":"Planning considerations for state, local, tribal, and territorial partners to receive medical countermeasures from CDC\u2019s Strategic National Stockpile during a public health emergency.","volume":"108","author":"Bhavsar","year":"2018","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R41","unstructured":"Food and Drug Administration. FDA approves new antibacterial treatment for plague. Washington, DC: U.S. Food and Drug Administration; 2012. https:\/\/wayback.archive-it.org\/7993\/20170111193903\/http:\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm302220.htm"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R42","unstructured":"Food and Drug Administration. FDA approves additional antibacterial treatment for plague. Washington, DC: U.S. Food and Drug Administration; 2015. https:\/\/web.archive.org\/web\/20180126014628\/https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm446283.htm"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R43","unstructured":"Laessig KA. Supplemental new drug application approval: Animal efficacy. Silver Spring, MD: U.S. Department of Health and Human Services, Food and Drug Administration; 2012. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2012\/020634s061,020635s067,021721s028ltr.pdf"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R44","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ijantimicag.2018.04.014","article-title":"Adverse events of fluoroquinolones vs. other antimicrobials prescribed in primary care: A systematic review and meta-analysis of randomized controlled trials.","volume":"52","author":"Tandan","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R45","unstructured":"Institute of Medicine. Crisis standards of care: A systems framework for catastrophic disaster response; 2012. Washington, DC: National Academies Press; 2012."},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R46","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1093\/cid\/ciz1230","article-title":"Treatment of human plague: A systematic review of published aggregate data on antimicrobial efficacy, 1939\u20132019.","volume":"70","author":"Godfred-Cato","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R47","unstructured":"National Notifiable Diseases Surveillance System. Plague (\n                      Yersinia pestis\n                      ). Atlanta, GA: U.S. Department of Health and Human Services, CDC. https:\/\/ndc.services.cdc.gov\/conditions\/plague"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R48","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1093\/cid\/ciz1231","article-title":"Safety of antimicrobials during pregnancy: A systematic review of antimicrobials considered for treatment and postexposure prophylaxis of plague.","volume":"70","author":"Yu","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R49","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1093\/cid\/ciz1233","article-title":"The African green monkey model of pneumonic plague and US Food and Drug Administration approval of antimicrobials under the animal rule.","volume":"70","author":"Hewitt","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R50","unstructured":"Food and Drug Administration. Animal rule information. Washington, DC: U.S. Department of Health and Human Services, Food and Drug Administration; 2018. https:\/\/www.fda.gov\/emergency-preparedness-and-response\/mcm-regulatory-science\/animal-rule-information"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R51","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/cpt.172","article-title":"The animal rule: The role of clinical pharmacology in determining an effective dose in humans.","volume":"98","author":"Bergman","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R52","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1086\/381545","article-title":"Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in New Mexico, 1985\u20131999.","volume":"38","author":"Boulanger","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R53","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3201\/eid0401.980114","article-title":"Plague, a reemerging disease in Madagascar.","volume":"4","author":"Chanteau","year":"1998","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.2019-3750","article-title":"Chemical-biological terrorism and its impact on children.","volume":"145","author":"Chung","year":"2020","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R55","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1128\/AAC.44.7.1995-1996.2000","article-title":"Susceptibilities of Yersinia pestis strains to 12 antimicrobial agents.","volume":"44","author":"Wong","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0000309","article-title":"Multiple antimicrobial resistance in plague: an emerging public health risk.","volume":"2","author":"Welch","year":"2007","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R57","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1574-695X.2008.00486.x","article-title":"Discrimination between biothreat agents and \u2018near neighbor\u2019 species using a resequencing array.","volume":"54","author":"Taitt","year":"2008","journal-title":"FEMS Immunol Med Microbiol"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R58","first-page":"35","article-title":"Chromosomal resistance of plague agent to quinolones","volume":"36","author":"Kasatkina","year":"1991","journal-title":"Antibiot Khimioter"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R59","first-page":"22","article-title":"Lack of levofloxacin and moxyfloxacin efficacy in experimental plague of albino mice infected with nalidixic acid resistant pathogen (Nal[r])","volume":"55","author":"Ryzhko","year":"2010","journal-title":"Antibiot Khimioter"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R60","first-page":"250","article-title":"Streptomycin in bubonic plague.","volume":"22","author":"Dubey","year":"1953","journal-title":"J Indian Med Assoc"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R61","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1179\/136485905X65161","article-title":"A 12-case outbreak of pharyngeal plague following the consumption of camel meat, in north-eastern Jordan.","volume":"99","author":"Arbaji","year":"2005","journal-title":"Ann Trop Med Parasitol"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R62","first-page":"339","article-title":"Streptomycin in experimental guinea pig pulmonary plague.","volume":"42","author":"Girard","year":"1949","journal-title":"Bull Soc Pathol Exot"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R63","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1177\/0897190014546836","article-title":"Aminoglycoside-induced nephrotoxicity.","volume":"27","author":"Wargo","year":"2014","journal-title":"J Pharm Pract"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2017.00308","article-title":"Aminoglycoside-induced cochleotoxicity: A review.","volume":"11","author":"Jiang","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R65","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.2215\/CJN.08140718","article-title":"Clinical pharmacology of antibiotics.","volume":"14","author":"Eyler","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0000959","article-title":"Levofloxacin cures experimental pneumonic plague in African green monkeys.","volume":"5","author":"Layton","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R67","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1093\/cid\/ciz1234","article-title":"Effect of delaying treatment on efficacy of ciprofloxacin and levofloxacin in the African green monkey model of pneumonic plague.","volume":"70","author":"Campbell","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R68","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/0002-9343(68)90171-X","article-title":"Pathogenesis of plague. A review of plague deaths in the United States during the last decade.","volume":"45","author":"Finegold","year":"1968","journal-title":"Am J Med"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R69","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.3201\/eid1109.050081","article-title":"Plague from eating raw camel liver.","volume":"11","author":"Saeed","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R70","doi-asserted-by":"publisher","first-page":"6429","DOI":"10.1016\/j.bmc.2016.08.049","article-title":"Plazomicin is effective in a non-human primate pneumonic plague model.","volume":"24","author":"Mega","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R71","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/01.CCM.0000150265.42067.4C","article-title":"Pharmacokinetics and intrapulmonary diffusion of levofloxacin in critically ill patients with severe community-acquired pneumonia.","volume":"33","author":"Boselli","year":"2005","journal-title":"Crit Care Med"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R72","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1378\/chest.125.3.965","article-title":"Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults.","volume":"125","author":"Capitano","year":"2004","journal-title":"Chest"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R73","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia: An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America.","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R74","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1542\/peds.2016-2706","article-title":"The use of systemic and topical fluoroquinolones.","volume":"138","author":"Jackson","year":"2016","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R75","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1097\/INF.0b013e3180cbd2c7","article-title":"Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.","volume":"26","author":"Bradley","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R76","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1128\/AAC.05043-11","article-title":"Lack of antimicrobial resistance in Yersinia pestis isolates from 17 countries in the Americas, Africa, and Asia.","volume":"56","author":"Urich","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R77","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1128\/AAC.00306-06","article-title":"Resistance of Yersinia pestis to antimicrobial agents.","volume":"50","author":"Galimand","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R78","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000334441","article-title":"QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications.","volume":"120","author":"Briasoulis","year":"2011","journal-title":"Cardiology"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R79","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1093\/jpids\/piy056","article-title":"Safety and tolerability of moxifloxacin in children.","volume":"7","author":"Dixit","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R80","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1755-5922.12054","article-title":"Antibiotic-induced cardiac arrhythmias.","volume":"32","author":"Abo-Salem","year":"2014","journal-title":"Cardiovasc Ther"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R81","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jpeds.2013.10.008","article-title":"Self-reported treatment practices by healthcare providers could lead to death from Rocky Mountain spotted fever.","volume":"164","author":"Zientek","year":"2014","journal-title":"J Pediatr"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R82","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jpeds.2015.02.015","article-title":"No visible dental staining in children treated with doxycycline for suspected Rocky Mountain Spotted Fever.","volume":"166","author":"Todd","year":"2015","journal-title":"J Pediatr"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R83","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1128\/AAC.40.11.2646","article-title":"In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus.","volume":"40","author":"Frean","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000094668","article-title":"Principles of antibiotic penetration into abscess fluid.","volume":"78","author":"Wagner","year":"2006","journal-title":"Pharmacology"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R85","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1128\/CMR.1.1.54","article-title":"Failure of aminoglycoside antibiotics to kill anaerobic, low-pH, and resistant cultures.","volume":"1","author":"Schlessinger","year":"1988","journal-title":"Clin Microbiol Rev"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R86","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/jac\/dkl489","article-title":"Combined effect of pH and concentration on the activities of gentamicin and oxacillin against Staphylococcus aureus in pharmacodynamic models of extracellular and intracellular infections.","volume":"59","author":"Baudoux","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R87","doi-asserted-by":"publisher","first-page":"e02434","DOI":"10.1128\/AAC.02434-16","article-title":"In vitro and in vivo activity of omadacycline against two biothreat pathogens, Bacillus anthracis and Yersinia pestis.","volume":"61","author":"Steenbergen","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R88","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/infdis\/133.5.493","article-title":"Yersinia pestis infection in Vietnam. II. Quantitative blood cultures and detection of endotoxin in the cerebrospinal fluid of patients with meningitis.","volume":"133","author":"Butler","year":"1976","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R89","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1086\/313804","article-title":"Cases of cat-associated human plague in the Western US, 1977\u20131998.","volume":"30","author":"Gage","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R90","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections.","volume":"23","author":"Nau","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R91","doi-asserted-by":"crossref","unstructured":"Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 Guideline for isolation precautions: Preventing transmission of infectious agents in healthcare settings. Atlanta, GA: U.S. Department of Health and Human Services, CDC, Healthcare Infection Control Practices Advisory Committee; 2019. https:\/\/www.cdc.gov\/infectioncontrol\/pdf\/guidelines\/isolation-guidelines-H.pdf","DOI":"10.1016\/j.ajic.2007.10.007"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R92","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1128\/AAC.38.3.481","article-title":"Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection.","volume":"38","author":"Bonacorsi","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R93","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/1471-0528.15119","article-title":"The safety of quinolones and fluoroquinolones in pregnancy: a meta-analysis.","volume":"125","author":"Yefet","year":"2018","journal-title":"BJOG"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R94","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1097\/AOG.0000000000002237","article-title":"Committee opinion no. 713: Antenatal corticosteroid therapy for fetal maturation.","volume":"130","author":"Committee on Obstetric Practice","year":"2017","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R95","doi-asserted-by":"publisher","first-page":"B2","DOI":"10.1016\/j.ajog.2019.01.216","article-title":"SMFM Consult Series #47: Sepsis during pregnancy and the puerperium.","volume":"220","author":"Plante","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R96","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1097\/AOG.0000000000003013","article-title":"ACOG Committee opinion no. 762: Prepregnancy counseling.","volume":"133","author":"Committee on Gynecologic Practice","year":"2019","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R97","first-page":"418","article-title":"Plague in a neonate.","volume":"135","author":"White","year":"1981","journal-title":"Am J Dis Child"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R98","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/bmj.1.4487.4","article-title":"Observations on plague meningitis.","volume":"1","author":"Landsborough","year":"1947","journal-title":"BMJ"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R99","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/BF01639529","article-title":"Influence of milk on the bioavailability of doxycycline\u2014new aspects.","volume":"17","author":"Meyer","year":"1989","journal-title":"Infection"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R100","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/clpt.1991.174","article-title":"Interference of dairy products with the absorption of ciprofloxacin.","volume":"50","author":"Neuvonen","year":"1991","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R101","unstructured":"Drugs and Lactation Database. Bethesda, MD: National Library of Medicine; 2006. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501922"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R102","unstructured":"Association for Promotion of and Cultural and Scientific Research into Breastfeeding. 2002. E-lactancia; 2002 http:\/\/e-lactancia.org"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R103","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s40124-013-0028-2","article-title":"Immunologic factors in human milk and disease prevention in the preterm infant.","volume":"1","author":"Gregory","year":"2013","journal-title":"Curr Pediatr Rep"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R104","doi-asserted-by":"publisher","first-page":"e827","DOI":"10.1542\/peds.2011-3552","article-title":"Breastfeeding and the Use of Human Milk","volume":"129","author":"Eidelman","year":"2012","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R105","unstructured":"National Library of Medicine. Ciprofloxacin: Drugs and lactation database (LactMed) Bethesda, MD: National Institutes of Health, National Library of Medicine; 2018."},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R106","unstructured":"National Library of Medicine. Ofloxacin: Drugs and lactation database (LactMed) Bethesda, MD: National Institutes of Health, National Library of Medicine; 2018."},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R107","unstructured":"National Library of Medicine. Gentamicin, tobramycin, and streptomycin: Drugs and lactation database (LactMed) Bethesda, MD: National Institutes of Health, National Library of Medicine; 2018."},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R108","unstructured":"National Library of Medicine. Tetracycline: Drugs and lactation database (LactMed). Bethesda, MD: National Institutes of Health, National Library of Medicine; 2018."},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R109","unstructured":"National Library of Medicine. Doxycycline: Drugs and lactation database (LactMed). Bethesda, MD: National Institutes of Health, National Library of Medicine; 2018."},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R110","first-page":"594","article-title":"Further observations on the use of tetracycline hydrochloride in prophylaxis and treatment of obstetric infections.","author":"Posner","year":"1954","journal-title":"Antibiot Annu"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R111","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1001\/archderm.1985.01660030139039","article-title":"Black galactorrhea as a consequence of minocycline and phenothiazine therapy.","volume":"121","author":"Basler","year":"1985","journal-title":"Arch Dermatol"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R112","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/j.1365-2133.1996.tb06332.x","article-title":"Black breast milk due to minocycline therapy.","volume":"134","author":"Hunt","year":"1996","journal-title":"Br J Dermatol"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R113","unstructured":"Miller RD, Salter AJ. The passage of trimethoprim\/sulfamethoxazole into breast milk and its significance. Antibacterial Chemotherapy 1974;1:687\u201391."},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R114","first-page":"24","article-title":"Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pregnant women: implications for resource-limited settings.","volume":"8","author":"Forna","year":"2006","journal-title":"AIDS Rev"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R115","unstructured":"National Library of Medicine. Trimethoprim-sulfamethoxazole: Drugs and lactation database (LactMed). Bethesda, MD: National Institutes of Health, National Library of Medicine; 2018."},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R116","unstructured":"National Library of Medicine. Chloramphenicol: Drugs and lactation database (LactMed). Bethesda, MD: National Institutes of Health, National Library of Medicine; 2018."},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R117","unstructured":"Cummings ED, Kongs EL, Edens MA. Gray baby syndrome. Treasure Island, FL: StatPearls Publishing, StatPearls Publishing LLC; 2020."},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R118","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000220550","article-title":"Excretion of chloramphenicol in human milk.","volume":"13","author":"Havelka","year":"1968","journal-title":"Chemotherapia (Basel)"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R119","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/infdis\/155.1.113","article-title":"Septicemic plague in New Mexico.","volume":"155","author":"Hull","year":"1987","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R120","first-page":"491","article-title":"9 epidemic cases of bubonic plague in Tananarive (Madagascar)","volume":"42","author":"Botton","year":"1982","journal-title":"Med Trop (Mars)"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R121","unstructured":"Villafane Lastra T, Goobar JK, Rodeiro M, Videla LF. Tratamiento de la peste de Oriente. Boletin Mensual Cordoba 1942;2:3\u201322."},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R122","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/jrnms-30-25","article-title":"Plague (bubonic and pneumonic) in Port Said.","volume":"30","author":"Townsend","year":"1944","journal-title":"J R Nav Med Serv"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R123","first-page":"347","article-title":"Plague\u2014San Juan County, New Mexico.","volume":"19","author":"Hirschfeld","year":"1970","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R124","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1093\/cid\/cis578","article-title":"Misidentification of Yersinia pestis by automated systems, resulting in delayed diagnoses of human plague infections\u2014Oregon and New Mexico, 2010\u20132011.","volume":"55","author":"Tourdjman","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R125","first-page":"725","article-title":"Imported plague\u2014New York City, 2002.","volume":"52","author":"CDC","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R126","first-page":"201","article-title":"Fatal laboratory-acquired infection with an attenuated Yersinia pestis Strain\u2014Chicago, Illinois, 2009.","volume":"60","author":"CDC","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R127","doi-asserted-by":"publisher","first-page":"k341","DOI":"10.1136\/bmj.k341","article-title":"Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study.","volume":"360","author":"Crellin","year":"2018","journal-title":"BMJ"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R128","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/phar.2023","article-title":"Comprehensive guidance for antibiotic dosing in obese adults.","volume":"37","author":"Meng","year":"2017","journal-title":"Pharmacotherapy"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R129","unstructured":"Monarch Pharmaceuticals. Chloramphenicol sodium succinate [package insert]. Bristol, TN: Monarch Pharmaceuticals; 2004."},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R130","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.clinthera.2015.05.495","article-title":"Pediatric obesity: Pharmacokinetics and implications for drug dosing.","volume":"37","author":"Kendrick","year":"2015","journal-title":"Clin Ther"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R131","first-page":"301813","article-title":"Population phamacokinetics of trimethoprim-sulfamethoxazole in infants and children.","volume":"62","author":"Autmizguine","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R132","doi-asserted-by":"publisher","first-page":"421","DOI":"10.5863\/1551-6776-24.5.421","article-title":"Evaluation of different methods used to calculate ideal body weight in the pediatric population.","volume":"24","author":"Kang","year":"2019","journal-title":"J Pediatr Pharmacol Ther"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R133","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5863\/1551-6776-22.1.81","article-title":"Medication dosage in overweight and obese children.","volume":"22","author":"Matson","year":"2017","journal-title":"J Pediatr Pharmacol Ther"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R134","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1038\/emi.2012.34","article-title":"Plague vaccines: current developments and future perspectives.","volume":"1","author":"Feodorova","year":"2012","journal-title":"Emerg Microbes Infect"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-019-0105-9","article-title":"Plague vaccine: recent progress and prospects.","volume":"4","author":"Sun","year":"2019","journal-title":"NPJ Vaccines"},{"key":"key-10.15585\/mmwr.rr7003a1-202107142042-R136","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00741","article-title":"Inhalational gentamicin treatment is effective against pneumonic plague in a mouse model.","volume":"9","author":"Gur","year":"2018","journal-title":"Front Microbiol"}],"container-title":["MMWR. Recommendations and Reports"],"original-title":[],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T06:06:15Z","timestamp":1672812375000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/70\/rr\/rr7003a1.htm?s_cid=rr7003a1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":136,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,7,16]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.rr7003a1","relation":{},"ISSN":["1057-5987","1545-8601"],"issn-type":[{"value":"1057-5987","type":"print"},{"value":"1545-8601","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,7,16]]},"published":{"date-parts":[[2021,7,16]]}}}